Delphinus Medical Technologies
PrivateLast Round
Convertible Debt
Apr 3, 2025
Total Funding Raised
$141.66M
Company Overview
Delphinus Medical Technologies operates in Healthcare & Life Sciences and is based in Novi, Michigan. Its latest recorded funding round was a Convertible Debt round in April 2025.
Delphinus Medical Technologies is a medical device company that develops and commercializes the SoftVue 3D whole-breast ultrasound tomography system for breast cancer screening.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Delphinus Medical Technologies Comparables
Compare Delphinus Medical Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iVu Imaging Corporation | 91% | |
| QT Imaging Holdings, Inc. | 86% | |
| iSono Health | 85% |
For institutional investors. Book with your work email.
Delphinus Medical Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Convertible Debt | Apr 3, 2025 | ||||
| Debt | Aug 22, 2023 | ||||
| Debt | Jun 22, 2023 | ||||
| Series D | Sep 29, 2022 | ||||
| Series C | Sep 10, 2015 | ||||
Series B | Sep 3, 2013 |
For institutional investors. Book with your work email.
Delphinus Medical Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Coast Technology Investors | Series A, Series D, Series B, Series C |
| Arboretum Ventures | Series D, Series C, Series B, Series A |
| Waycross Ventures | Series D, Series C |
| Beringea | Series D, Series C, Series A, Series B |
| Venture Investors LLC | Series D, Series C |
| Trinity Capital | Debt |
| Hopen Life Science Ventures | Series D, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2023
$12M round led by Trinity Capital.
- Jun 22, 2023
$4.5M debt round led by Trinity Capital
For institutional investors. Book with your work email.
Delphinus Medical Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Delphinus Medical Technologies's valuation, stock price, and market status.
Is Delphinus Medical Technologies a public or private company?
Delphinus Medical Technologies is a private company.
What is the current stock price of Delphinus Medical Technologies?
Delphinus Medical Technologies is a private company, so its shares have no public market price. Caplight tracks Delphinus Medical Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Delphinus Medical Technologies worth (valuation)?
Valuation information for Delphinus Medical Technologies is not publicly available.
Can I buy Delphinus Medical Technologies stock?
Delphinus Medical Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Delphinus Medical Technologies's last funding round?
Delphinus Medical Technologies's most recent funding round was Convertible Debt on April 3, 2025.
Who are the main investors in Delphinus Medical Technologies?
Key investors in Delphinus Medical Technologies include Arboretum Ventures, Beringea, Venture Investors LLC, Trinity Capital.
Will Delphinus Medical Technologies IPO soon?
No public IPO plans have been announced for Delphinus Medical Technologies.
How can I track Delphinus Medical Technologies secondary market activity?
Caplight tracks bids, offers, and trades in Delphinus Medical Technologies's shares on secondary markets.